Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Dr Ed Schwalbe
Newcastle Authors
Title
Year
Full text
Dr Florence Burté
Magretta Adiamah
Dr Fatma Scerif
Dr Debbie Hicks
Dr Ed Schwalbe
et al.
Metabolite profiles of medulloblastoma for rapid and non-invasive detection of molecular disease groups
2024
Professor Steven Clifford
Dr Ed Schwalbe
Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome
2023
James Hacking
Dr Dean Thompson
Dr Ed Schwalbe
Professor Steven Clifford
Dr Daniel Williamson
Deriving a continuum score for group 3 and 4 medulloblastoma tumor samples analyzed via RNA-sequencing or DNA methylation microarray
2023
Dr Simon Bomken
Dr Amir Enshaei
Dr Ed Schwalbe
Dr Aneta Mikulasova
Dr Masood Zaka
et al.
Molecular characterisation and clinical outcome of B-cell precursor acute lymphoblastic leukaemia with
IG-MYC
rearrangement
2023
Dr Daniel Williamson
Dr Ed Schwalbe
Professor Simon Bailey
Professor Steven Clifford
Timing is everything: A connection between medulloblastoma prognosis and foetal cerebellar development
2023
Dr Stacey Richardson
Dr Rebecca Hill
Dr Christopher Kui
Dr Janet Lindsey
Dr Yura Grabovska
et al.
Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse
2022
Dr Jack Goddard
Dr Jemma Castle
Emily Southworth
Anya Fletcher
Dr Stephen Crosier
et al.
MEDB-71. Molecular characterisation of Group 4 medulloblastoma improves risk-stratification and its biological understanding
2022
Dr Daniel Williamson
Dr Ed Schwalbe
Dr Debbie Hicks
Dr Janet Lindsey
Dr Stephen Crosier
et al.
Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar development
2022
Dr Marina Danilenko
Dr Claire Keeling
Dr Stephen Crosier
Dr Martina Finetti
Dr Daniel Williamson
et al.
Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma development
2022
Ruxandra Neatu
Dr Dean Thompson
Dr Ed Schwalbe
Dr Stephany Veuger
The Idiopathic Pulmonary Fibrosis-Associated Single Nucleotide Polymorphism RS35705950 Is Transcribed in a MUC5B Promoter Associated Long Non-Coding RNA (AC061979.1)
2022
Dr Stephen Crosier
Dr Debbie Hicks
Dr Ed Schwalbe
Dr Daniel Williamson
Amanda Smith
et al.
Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnostics
2021
Dr Ed Schwalbe
- Lalchungnunga
Dr Timothy Barrow
Dr Gordon Strathdee
Integration of genome-level data to allow identification of subtype-specific vulnerability genes as novel therapeutic targets
2021
Dr Marina Danilenko
Professor Steven Clifford
Dr Ed Schwalbe
Inter and intra-tumoral heterogeneity as a platform for personalized therapies in medulloblastoma
2021
Dr Debbie Hicks
Dr Reza Rafiee
Dr Ed Schwalbe
Dr Christopher Howell
Dr Janet Lindsey
et al.
The molecular landscape and associated clinical experience in infant medulloblastoma: prognostic significance of second-generation subtypes
2021
Dr Ed Schwalbe
Dr Peter Carey
Professor Stephen O'Brien
Professor Anthony Moorman
Emilio Barretta
et al.
Challenges of starting treatment protocols for acute lymphoblastic leukaemia in a low-income setting — the Blantyre experience
2020
1
2
3